Biodesix, Inc. Common Stock (BDSX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDSX trades at $14.37 with a market cap of $144.05M and a P/E ratio of -3.06. BDSX moved +2.33% today. Year to date, BDSX is +130.66%; over the trailing twelve months it is +165.32%. Its 52-week range spans $3.44 to $36.00. Analyst consensus is strong buy with an average price target of $30.67. Rallies surfaces BDSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BDSX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDSX recently traded at $14.37. Market cap is $144.05M. P/E ratio is -3.06. Revenue is $88.50M.
| Metric | Value |
|---|---|
| Price | $14.37 |
| Market Cap | $144.05M |
| P/E Ratio | -3.06 |
| EPS | $-4.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.00 |
| 52-Week Low | $3.44 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $88.50M |
| Net Income | $-35.27M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $88.50M | $-35.27M | $-4.67 |
| 2023 | $49.09M | $-52.15M | $-0.64 |
| 2022 | $38.21M | $-65.45M | $-1.55 |
| 2021 | $54.51M | $-43.16M | $0.00 |
5 analysts cover BDSX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.67.